Literature DB >> 8727711

Comparative study of C-reactive protein in chronic hepatitis B and chronic hepatitis C.

M Shima1, K Nakao, Y Kato, K Nakata, N Ishii, S Nagataki.   

Abstract

C-reactive protein (CRP) is a liver-specific acute-phase protein, and its expression in hepatocyte is regulated by cytokines such as interleukin-1, interleukin-6 and tumor necrosis factor-alpha. Although several alterations in cytokines have been found in patients with chronic viral hepatitis, it remains obscure how CRP expression is associated with progression of the disease in chronic viral infection. In the present study, CRP expression was evaluated in 45 patients with chronic hepatitis B and in 38 patients with chronic hepatitis C. By the immunohistochemical analysis, the intensity of CRP expression in hepatocyte was closely associated with the histology activity index (HAI) score in chronic hepatitis B. In contrast, the association was not found in chronic hepatitis C. When serial changes in serum levels of CRP were compared in long-term follow-up patients including 5 patients with chronic hepatitis B and 4 patients with chronic hepatitis C, serum levels of CRP fluctuated simultaneously with serum levels of alanine aminotransferase in chronic hepatitis B, whereas the correlation was not recognized in chronic hepatitis C. These results suggest that CRP expression correlates with progression of the disease in chronic hepatitis B, but not in chronic hepatitis C. It is also possible that cytokine-mediated response is more pronounced in chronic hepatitis B than in chronic hepatitis C.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8727711     DOI: 10.1620/tjem.178.287

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  7 in total

1.  The relationship between visfatin, liver inflammation, and acute phase reactants in chronic viral hepatitis B.

Authors:  Enver Yüksel; Erdem Akbal; Erdem Koçak; Ömer Akyürek; Seyfettin Köklü; Fuat Ekiz; Barış Yılmaz
Journal:  Wien Klin Wochenschr       Date:  2015-04-09       Impact factor: 1.704

2.  Association between high-sensitivity C-reactive protein and N-Terminal Pro-B-Type Natriuretic Peptide in patients with hepatitis C virus infection.

Authors:  Wenliang Che; Buchun Zhang; Wenling Liu; Yidong Wei; Yawei Xu; Dayi Hu
Journal:  Mediators Inflamm       Date:  2012-05-08       Impact factor: 4.711

3.  A preliminary study of inflammatory markers in non-alcoholic steatohepatitis patients.

Authors:  Manopriya T Priya; Dhastagir Sultan Sheriff
Journal:  Libyan J Med       Date:  2010-03-19       Impact factor: 1.657

4.  Cardiovascular disease risk in patients with hepatitis C infection: Results from two general population health surveys in Canada and the United States (2007-2017).

Authors:  Alaa Badawi; Giancarlo Di Giuseppe; Paul Arora
Journal:  PLoS One       Date:  2018-12-12       Impact factor: 3.240

5.  Predictive role of acute phase reactants in the response to therapy in patients with chronic hepatitis C virus infection.

Authors:  Ayten Oguz; Ahmet Engin Atay; Adnan Tas; Gulseren Seven; Mehmet Koruk
Journal:  Gut Liver       Date:  2012-11-13       Impact factor: 4.519

6.  Transcriptome analysis of duck liver and identification of differentially expressed transcripts in response to duck hepatitis A virus genotype C infection.

Authors:  Cheng Tang; Daoliang Lan; Huanrong Zhang; Jing Ma; Hua Yue
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

7.  ESTIMATION OF IMMUNOLOGICAL AND BIOCHEMICAL PARAMETERS IN HEPATITIS B POSITIVE PATIENTS.

Authors:  J K Molade; A A Onifade; M A Jimoh; O G Oyero; I C Ahube; O K Olawuyi; I Ayodeji
Journal:  Ann Ib Postgrad Med       Date:  2020-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.